RESULTS : Among the 87 identified studies examining genetic associations with MTX efficacy and toxicity , the reduced folate carrier 1 gene ( RFC1 ) variant 80G>A ( Arg ( 27 ) His , rs1051266 ) was selected for random-effects meta-analysis .